RBC Technology Ventures

RBC Technology Ventures is the corporate venture capital arm of the Royal Bank of Canada (RBC), specializing in early-stage investments across North America. The firm focuses on high-growth sectors including life sciences, healthcare, information technology, and clean technology. Historically, it has played a significant role in the Canadian biotech ecosystem through initiatives like the Milestone Medica Corporation and the VIMAC Milestone Medica Fund, which were designed to commercialize biomedical research from Canadian universities. As a subsidiary of Canada's largest bank, it provides not only equity financing but also access to RBC's global network and expertise to help scale innovative technologies. Its portfolio has included notable companies in drug delivery, antisense therapeutics, and medical devices.